Biotech

All Articles

Galapagos' stock up as fund presents intent to shape its evolution

.Galapagos is actually happening under added tension from clients. Having actually created a 9.9% co...

Cell- focused Sana gathers very first CSO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of significant leadership hirings, firings a...

Allist pays off Jacobio $21M, landing job in Chinese KRAS nationality

.Shanghai Allist Pharmaceuticals has acquired on its own a starring character in China's KRAS market...

ReNeuron leaving purpose substitution after missing out on fundraising goal

.ReNeuron has actually signed up with the long checklist of biotechs to leave London's intention sto...

MBX apply for IPO to take opposition to Ascendis into period 3

.MBX Biosciences has included in the recent spurt of IPO filings. The biotech, which submitted its d...

FDA broadens probing into Lykos' MDMA tests: WSJ

.For Lykos Therapies and the business's prospective MDMA-assisted therapy for trauma (PTSD), the fav...

Gene editor Volume laying off 131 laborers

.Merely times after genetics publisher Volume Biosciences declared unrevealed working cuts, a more c...

Repare gives up 25% of team as biotech stops preclinical R&ampD

.Repare Rehab is laying off a fourth of its workforce as the oncology biotech scales back its precli...

J &amp J apply for FDA confirmation of $6.5 B autoimmune drug

.Johnson &amp Johnson has gotten yet another step towards recognizing a profit on its own $6.5 billi...

Gain's stage 1 win leads method to confirm Parkinson's drug's worth

.Gain Therapeutics has actually specified its sights on confirming the effectiveness of its Parkinso...